Robert Flamini

3.3k total citations · 1 hit paper
21 papers, 957 citations indexed

About

Robert Flamini is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert Flamini has authored 21 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 11 papers in Pediatrics, Perinatology and Child Health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert Flamini's work include Epilepsy research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Neuroscience and Neuropharmacology Research (5 papers). Robert Flamini is often cited by papers focused on Epilepsy research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Neuroscience and Neuropharmacology Research (5 papers). Robert Flamini collaborates with scholars based in United States, United Kingdom and Italy. Robert Flamini's co-authors include Linda Laux, Elizabeth A. Thiele, Orrin Devinsky, Ian Miller, Anup D. Patel, Angus A. Wilfong, Beth A. Malow, Jerzy P. Szaflarski, Laurie E. Seltzer and E. Martina Bebin and has published in prestigious journals such as Neurology, Epilepsia and Headache The Journal of Head and Face Pain.

In The Last Decade

Robert Flamini

19 papers receiving 909 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

2018 340 citations Orrin Devinsky, Anup D. Patel et al. Neurology profile →

Peers

Countries citing papers authored by Robert Flamini

Since Specialization

Citations

This map shows the geographic impact of Robert Flamini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Flamini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Flamini more than expected).

Fields of papers citing papers by Robert Flamini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Flamini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Flamini. The network helps show where Robert Flamini may publish in the future.

Co-authorship network of co-authors of Robert Flamini

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Flamini. A scholar is included among the top collaborators of Robert Flamini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Flamini. Robert Flamini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term Effectiveness of Cannabidiol (CBD) Against Focal-onset Seizures in Treatment-resistant Epilepsies (TRE): Experience from the Expanded Access Program (EAP) (S29.005) 2024 ·Neurology ·Yong Park, Karthik Rajasekaran, Teresa Greco, (unknown), Robert Flamini	0
2	Stress and Quality of Life of Parents of Children With POLR3-Related Leukodystrophy: A Cross-Sectional Pilot Study 2024 ·Journal of Child Neurology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Robert Flamini, Andrea Rossi, (unknown), Enrico Bertini, Francesco Nicita, Daniela Pohl, Sunita Venkateswaran, Stephanie Keller, Elsa Rossignol, Deborah L. Renaud, (unknown), Xiaoru Chen, Adeline Vanderver, Geneviève Bernard	0
3	Adaptive functioning and neurodevelopment in patients with Dravet syndrome: 12-month interim analysis of the BUTTERFLY observational study 2024 ·Epilepsy & Behavior ·Joseph Sullivan, Elaine Wirrell, Kelly G. Knupp, (unknown), Robert Flamini, Muhammad Zafar, Pamela Ventola, Javier Avendaño, Wang Fei, (unknown), Barry Ticho	10
4	Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment‐resistant epilepsies in the Expanded Access Program 2023 ·Epilepsia ·Robert Flamini, Anne M. Comi, E. Martina Bebin, Michael Chez, Gary Clark, Orrin Devinsky, Shaun A. Hussain, Paul D. Lyons, Anup D. Patel, (unknown), Farhad Sahebkar, Eric Segal, Laurie E. Seltzer, Jerzy P. Szaflarski, Arie Weinstock	13
5	Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment 2023 ·Neurotherapeutics ·Allan Bayat, (unknown), Francesco Miceli, (unknown), Katrine M. Johannesen, Marina Nikanorova, Rafał Płoski, Krystyna Szymańska, Robert Flamini, Edward C. Cooper, Sarah Weckhuysen, Maurizio Taglialatela, Rikke S. Møller	5
6	Interim results of adaptive functioning and neurodevelopment in BUTTERFLY – An observational study of children and adolescents with Dravet syndrome 2022 ·Epilepsy & Behavior ·Joseph Sullivan, Elaine Wirrell, Kelly G. Knupp, (unknown), Muhammad Zafar, Robert Flamini, (unknown), (unknown), (unknown), Javier Avendaño, (unknown), (unknown), Barry Ticho	5
7	Progression of alternating hemiplegia of childhood‐related focal epilepsy to electrical status epilepticus in sleep with reversible encephalopathy 2022 ·Epileptic Disorders ·(unknown), (unknown), Lyndsey Prange, Robert Flamini, Mohamad A. Mikati	3
8	Long-term Safety and Efficacy of Adjunctive Perampanel in Pediatric Patients (Aged 4 to <12 years) with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) in Study 311 (413) 2020 ·Neurology ·Robert Flamini, Anna Patten, Leock Y. Ngo	2
9	Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures 2020 ·Epilepsia ·András Fogarasi, Robert Flamini, Mathieu Milh, Steven Phillips, (unknown), Anna Patten, (unknown), Antonio Laurenza, Leock Y. Ngo	47
10	Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results 2019 ·Epilepsy Research ·Linda Laux, E. Martina Bebin, Daniel Checketts, Michael Chez, Robert Flamini, Eric D. Marsh, Ian Miller, Kathryn Nichol, Yong Park, Eric Segal, Laurie E. Seltzer, Jerzy P. Szaflarski, Elizabeth A. Thiele, Arie Weinstock	143
11	Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes 2018 ·Epilepsy & Behavior ·Orrin Devinsky, Chloe Verducci, Elizabeth A. Thiele, Linda Laux, Anup D. Patel, Francis Filloux, Jerzy P. Szaflarski, Angus A. Wilfong, Gary Clark, Yong D. Park, Laurie E. Seltzer, E. Martina Bebin, Robert Flamini, Robert Wechsler, Daniel Friedman	136
12	Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome breakdown → 2018 ·Neurology ·Orrin Devinsky, Anup D. Patel, Elizabeth A. Thiele, Matthew H. Wong, Richard Appleton, Cynthia L. Harden, Sam M. Greenwood, Gilmour Morrison, Kenneth W. Sommerville, (unknown), (unknown), Angus A. Wilfong, Robert Flamini, Linda Laux, Ian Miller, J. Helen Cross, Charuta Joshi, Richard Chin, Sameer M. Zuberi	340
13	Response of Subependymal Giant Cell Astrocytoma With Spinal Cord Metastasis to Everolimus 2013 ·Journal of Pediatric Hematology/Oncology ·Dolly Aguilera, Robert Flamini, Claire Mazewski, Matthew Schniederjan, Laura L. Hayes, William Boydston, Robert C. Castellino, Tobey J. MacDonald	9
14	74 The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma 2012 ·European Urology Supplements ·Sergiusz Jóźwiak, Е. Д. Белоусова, Christopher Kingswood, Michael Frost, Rachel Kuperman, Martina Bebin, Bruce R. Korf, Robert Flamini, Michael Kohrman, Steven Sparagana, Joyce Y. Wu, Tarek Sahmoud, Gaurav Shah, David Neal Franz	3
15	Rufinamide from clinical trials to clinical practice in the United States and Europe 2011 ·Epileptic Disorders ·Trevor Resnick, Alexis Arzimanoglou, Lawrence W. Brown, Robert Flamini, Michael Kerr, Gerhard Kluger, Sanjeev V. Kothare, (unknown), (unknown), Milind M. Narurkar	12
16	The efficacy of felbamate as add-on therapy to valproic acid in the Lennox–Gastaut syndrome 1999 ·Epilepsy Research ·Heidi E. Siegel, Kathleen Kelley, (unknown), Patricia Reeves‐Tyer, Robert Flamini, Beth A. Malow, (unknown), David Ko, (unknown)	39
17	Felbamate monotherapy has stimulant-like effects in patients with epilepsy 1996 ·Epilepsy Research ·T A Ketter, Beth A. Malow, Robert Flamini, (unknown), Steven R. White, Robert M. Post, William H. Theodore	40
18	Felbamate Monotherapy: Implications for Antiepileptic Drug Development 1995 ·Epilepsia ·William H. Theodore, Paul Albert, (unknown), Beth A. Malow, David Ko, Steven R. White, Robert Flamini, (unknown)	31
19	FDG-PET in children and adolescents with partial seizures: Role in epilepsy surgery,evaluation 1995 ·Epilepsy Research ·William D. Gaillard, Silke White, Beth A. Malow, Robert Flamini, (unknown), Susumu Satô, Conrad Kufta, Steven J. Schiff, Orrin Devinsky, S. Fazilat, P.G. Reeves, W. H. Theodore	50
20	Anticonvulsant withdrawal‐emergent psychopathology 1994 ·Neurology ·T A Ketter, Beth A. Malow, Robert Flamini, Steven R. White, Robert M. Post, W. H. Theodore	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact